AI assistant
Sending…
Aquestive Therapeutics, Inc. — Director's Dealing 2021
Jan 8, 2021
32552_dirs_2021-01-08_6cea194c-fb53-499c-af30-f3017e41fc93.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Aquestive Therapeutics, Inc. (AQST)
CIK: 0001398733
Period of Report: 2020-12-31
Reporting Person: TOTH A ERNEST JR (N/A)
More from Aquestive Therapeutics, Inc.
Annual Report
2026
Apr 24
Regulatory Filings
2026
Mar 30
Regulatory Filings
2026
Mar 20
Regulatory Filings
2026
Feb 26
Regulatory Filings
2026
Feb 2
Regulatory Filings
2026
Jan 21
Regulatory Filings
2026
Jan 9
Director's Dealing
2025
Dec 5
Director's Dealing
2025
Dec 4
Regulatory Filings
2025
Nov 17